A glycogen synthase kinase-3 (GSK-3) inhibitor. Effects of GSK inhibitors on p-tau, GSK-3β activities and cell death were measured in a human neuronal cell line (LUHMES). Lithium and CHIR98014 reduced tau phosphorylation (Ser396) in the cortex and hippocampus. Inhibition of GSK-3 is recently regarded as one of the viable approaches to therapy for Alzheimer's disease, cancer, diabetes mellitus, osteoporosis, and bipolar mood disorder.
SKU | RCLST001292 |
---|---|
CAS number | 556813-39-9 |
Molecular Formula | C20H17Cl2N9O2 |
Catalog Number | RCLST001292 |
Chemical Name | CHIR-98014 |
Synonyms | N6-[2-[[4-(2,4-Dichlorophenyl)-5-(1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]-3-nitro- 2,6-pyridinediamine; |
Molecular Weight | 486.31 |
Solubility | DMSO, Methanol |
Stability | No Data Available |
Appearance | Yellow Solid |
Storage Condition | Refrigerator |
Shipping Info | *eh* Dangerous Goods |